Trial · NCT07901257
Social Software-Based Intelligent Management System for Bowel Preparation
NCT07901257, Not applicable, Not yet recruiting, Shandong University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Social Software-Based Intelligent Management System for Bowel Preparation. Trials, record NCT07901257. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07901257
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Social Software-Based Intelligent Management System for Bowel Preparation
- NCT number
- NCT07901257
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 740 participants, estimated
- Lead sponsor
- Shandong University
- Conditions
- Colorectal Polyp, Colorectal Adenoma, Bowel Preparation, Artificial Intelligence
- Interventions
- AI-assisted Bowel Preparation Management, Conventional Bowel Preparation Management
- First posted
- 2026-10-28
- Last updated
- 2026-10-28
Source ClinicalTrials.gov
Registered outcomes9
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Bowel Preparation Quality Assessed by the Boston Bowel Preparation Scale (BBPS) | During colonoscopy. | Bowel preparation quality will be assessed using the Boston Bowel Preparation Scale (BBPS). The total BBPS score ranges from 0 to 9. Excellent bowel preparation is defined as a total BBPS score ≥8. Adequate bowel preparation is defined as a total BBPS score ≥6, with a score ≥2 in each colonic segment. |
| Secondary | Polyp Detection Rate (PDR) | During colonoscopy. | Polyp detection rate is defined as the proportion of participants in whom at least one colorectal polyp is detected during colonoscopy. |
| Secondary | Adenoma Detection Rate (ADR) | From colonoscopy to completion of histopathological assessment. | Adenoma detection rate is defined as the proportion of participants in whom at least one histologically confirmed colorectal adenoma is detected during colonoscopy. |
| Secondary | Cecal Intubation Rate | During colonoscopy. | Cecal intubation rate is defined as the proportion of colonoscopy procedures in which the colonoscope successfully reaches the cecum. |
| Secondary | Insertion Time | During colonoscopy. | Insertion time is defined as the time from insertion of the colonoscope through the anus to successful intubation of the cecum. |
| Secondary | Withdrawal Time | During colonoscopy. | Withdrawal time is defined as the time from the start of colonoscope withdrawal from the cecum to complete removal of the colonoscope. |
| Secondary | Patient Satisfaction | Day 1 (After completion of bowel preparation and before colonoscopy) | Patient satisfaction with bowel preparation education and management will be assessed after completion of bowel preparation using the study-specific satisfaction questionnaire or rating scale. |
| Secondary | Patient Tolerance | Day 1 (After completion of bowel preparation and before colonoscopy) | Patient tolerance of bowel preparation will be assessed based on sleep quality during bowel preparation and willingness to undergo the same bowel preparation regimen again in the future. |
| Secondary | Bowel Preparation-related Discomfort Symptoms checklist | Day 1 (From the start of bowel preparation to colonoscopy) | Bowel preparation-related discomfort symptoms, including abdominal pain, abdominal distension, nausea, vomiting, and other adverse symptoms, will be recorded after completion of bowel preparation. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07901257
GET https://conductscience.org/api/trials/v1/NCT07901257/registered